CORDIS
EU research results

CORDIS

English EN
Novel molecular drug targets for obesity and type 2 diabetes

Novel molecular drug targets for obesity and type 2 diabetes

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

GÖTEBORG UNIVERSITY

Address

Vasaparken
100 GÖTeborg

Sweden

Administrative Contact

Suzanne DICKSON (Prof.)

Participants (24)

Sort alphabetically

Expand all

UNIVERSITY OF COPENHAGEN

Denmark

GENOME RESEARCH LIMITED

United Kingdom

IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

United Kingdom

MEDICAL RESEARCH COUNCIL

United Kingdom

UNIVERSIDADE DE SANTIAGO DE COMPOSTELA

Spain

INGENIUM PHARMACEUTICALS AG

Germany

INTEGRAGEN SA

France

THE UNIVERSITY OF EDINBURGH

United Kingdom

INSTITUTE OF EXPERIMENTAL MEDICINE, HUNGARIAN ACADEMY OF SCIENCES

Hungary

KAROLINSKA INSTITUTET

Sweden

THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN

United Kingdom

THE CHANCELLOR, MASTER AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE

United Kingdom

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

France

GENEVA UNIVERSITY

Switzerland

INSTITUT PASTEUR DE LILLE

France

EUROPEAN MOLECULAR BIOLOGY LABORATORY

Germany

DEUTSCHE INSTITUT FUER EMAEHRUNGSFORSCHUNG, POTSDAM-REHBRUECKE

Germany

ALMA MATER STUDIORUM - UNIVERSITÀ DI BOLOGNA - DIPARTEMENTO DI MEDICINA INTERNA E GASTROENTEROLOGIA

Italy

DEVELOGEN AKTIENGESELLSCHAFT FÜR ENTWICKLUNGSBIOLOGISCHE FORSCHUNG

Germany

PHILIPPS UNIVERSITÄT MARBURG

Germany

THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN

Ireland

UNIVERSITÀ DEGLI STUDI DI TORINO

Italy

UNIVERSITÄT DUISBURG-ESSEN

Germany

UNIVERSITÄT ZU KÖLN

Germany

Project information

Grant agreement ID: 503041

  • Start date

    1 January 2004

  • End date

    31 December 2008

Funded under:

FP6-LIFESCIHEALTH

  • Overall budget:

    € 13 765 559

  • EU contribution

    € 11 601 083

Coordinated by:

GÖTEBORG UNIVERSITY

Sweden